IPCA MMF-S 360 Tablet

Product Description

IPCA MMF-S 360 Tablet contains Mycophenolate Sodium, an immunosuppressive agent used primarily to prevent organ rejection in transplant recipients. It prevents the immune system from attacking the transplanted organ by lowering its activity.

Pregnant or nursing women should not take this medication since it may result in birth abnormalities. Because of potential drug interactions, let your doctor know about any infections, blood disorders, stomach troubles, or any medications you're taking.

Brand Name: Ipca Mmf

Composition: Mycophenolate Sodium

Mechanism of Action:

An enzyme that aids in the growth of lymphocytes, immune cells that attack foreign tissue is inhibited by mycophenolate sodium. Mycophenolate lowers immunological responses by reducing the creation of lymphocytes, which helps to keep the body from rejecting the transplanted organ.

Uses:

Prevention of Organ Rejection

Dosage and Administration:

Although dosages may differ based on the particular organ transplant and patient demands, 720 mg twice daily is often advised for kidney transplant recipients. taken orally, unless a healthcare professional instructs you otherwise, preferably on an empty stomach for best absorption.

Side Effects:

• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Leukopenia (low white blood cell count)
• Anemia
• Headache
• Dizziness
• Fatigue